Visteon cuts 2026 adjusted EBITDA outlook to $370 million-$410 million on warranty charges
Bitget2026/10/22 11:33- Visteon raised its full-year 2026 sales forecast by $25 million to $3.8 billion-$3.85 billion, with launches offsetting lower customer production.
- Adjusted EBITDA guidance fell to $370 million-$410 million, including $77 million in exceptional warranty charges.
- Adjusted free cash flow is projected at $90 million-$130 million, with the midpoint reduced to reflect strategic inventory building.
- Fourth-quarter demand remains strong, but tightening memory and semiconductor supplies limit further sales upside.
- Third-quarter sales reached $970 million, with growth-over-market of 10% driven by product launches.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GM cancels long-term rare earth permanent magnet supply agreement in the US; supplier initiates arbitration
General Motors (GM.US) has canceled a long-term supply agreement with a U.S. rare earth permanent magnet manufacturer, and both parties are currently undergoing arbitration.
Tom Lee Says Yields Below 5% Mean the AI Selloff Is Nearly Over
Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) will be listed on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 millions.
Lycia will issue 17.64 million shares at a price of $18 per share to raise $317.5 million.
Crypto prices
More
